This is a table of type bigram and their frequencies. Use it to search & browse the list to learn more about your study carrel.
bigram | frequency |
---|---|
respiratory syndrome | 203 |
middle east | 174 |
east respiratory | 147 |
syndrome coronavirus | 138 |
public health | 97 |
respiratory viruses | 97 |
acute respiratory | 91 |
coronavirus disease | 88 |
novel coronavirus | 87 |
saudi arabia | 86 |
dromedary camels | 71 |
risk factors | 64 |
respiratory syncytial | 61 |
syncytial virus | 60 |
severe acute | 56 |
respiratory virus | 53 |
mortality rates | 53 |
respiratory infections | 51 |
statistically significant | 51 |
clinical characteristics | 51 |
influenza vaccination | 50 |
world health | 49 |
viral shedding | 48 |
cov cases | 47 |
health organization | 45 |
symptom onset | 44 |
infect doi | 42 |
epidemiol infect | 42 |
cord uid | 42 |
doc id | 42 |
viral infection | 41 |
infectious diseases | 41 |
respiratory tract | 40 |
current study | 40 |
logistic regression | 40 |
viral infections | 39 |
healthcare workers | 37 |
study period | 37 |
index case | 36 |
control measures | 36 |
two groups | 36 |
mortality rate | 36 |
virus infection | 36 |
confirmed cases | 35 |
hong kong | 35 |
influenza virus | 34 |
seasonal influenza | 34 |
significantly higher | 33 |
family cluster | 33 |
respiratory viral | 32 |
respiratory illness | 31 |
infection control | 30 |
health care | 30 |
united states | 30 |
young children | 30 |
illness onset | 30 |
regression analysis | 29 |
adult patients | 29 |
coronavirus infection | 29 |
severe group | 29 |
rna detection | 28 |
significant difference | 28 |
fever clinics | 28 |
respiratory symptoms | 27 |
virus infections | 27 |
infectious disease | 27 |
confidence interval | 27 |
previous studies | 27 |
shedding duration | 27 |
case fatality | 27 |
age groups | 26 |
viral respiratory | 26 |
systematic review | 26 |
survival rates | 26 |
factors associated | 26 |
incubation period | 25 |
critically ill | 25 |
aged years | 25 |
least one | 25 |
clinical symptoms | 25 |
reproduction number | 24 |
severe covid | 24 |
nasal swabs | 24 |
new cases | 24 |
disease control | 23 |
confirmed covid | 23 |
risk perception | 23 |
severe cases | 23 |
significant differences | 23 |
lower respiratory | 23 |
viral load | 22 |
age group | 22 |
influenza vaccine | 22 |
clinical features | 22 |
suspected cases | 22 |
first case | 22 |
cohort study | 21 |
cov infection | 21 |
tested positive | 21 |
time series | 21 |
viral rna | 21 |
influenza mortality | 21 |
sporadic cases | 21 |
total number | 20 |
fatality rate | 20 |
human transmission | 20 |
median age | 20 |
rsv infection | 20 |
rp findings | 20 |
mortality outcome | 20 |
chain reaction | 19 |
years old | 19 |
mers patients | 19 |
polymerase chain | 19 |
vaccination behaviours | 19 |
lymphocyte ratio | 19 |
pandemic influenza | 19 |
attack rate | 18 |
based hand | 18 |
cov outbreak | 18 |
poor prognosis | 18 |
dromedary camel | 18 |
care workers | 18 |
basic reproduction | 17 |
supplementary table | 17 |
bcg vaccination | 17 |
reported cases | 17 |
illness severity | 17 |
national health | 17 |
family members | 17 |
household members | 17 |
coronavirus infections | 17 |
european countries | 16 |
cumulative attack | 16 |
index cases | 16 |
sore throat | 16 |
chest ct | 16 |
never vaccinated | 16 |
nucleic acid | 16 |
transmission dynamics | 16 |
patients infected | 16 |
risk factor | 16 |
mobile hospital | 16 |
continuous variables | 16 |
detection results | 16 |
retrospective study | 16 |
less likely | 16 |
global health | 16 |
categorical variables | 16 |
asymptomatic cases | 16 |
supplementary material | 15 |
one virus | 15 |
yellow fever | 15 |
hand hygiene | 15 |
family clusters | 15 |
critical care | 15 |
older age | 15 |
ill patients | 15 |
hospitalized patients | 15 |
mers coronavirus | 15 |
children aged | 15 |
upper respiratory | 15 |
regression model | 15 |
social distancing | 15 |
cov rna | 15 |
human metapneumovirus | 15 |
critical illness | 15 |
intensive care | 15 |
early stage | 14 |
lymphocyte counts | 14 |
system dynamics | 14 |
within days | 14 |
th february | 14 |
severe disease | 14 |
virus transmission | 14 |
respiratory infection | 14 |
financial support | 14 |
cause mortality | 14 |
close contact | 14 |
linear regression | 14 |
bedouin arabs | 14 |
study showed | 14 |
significantly lower | 14 |
clinical course | 14 |
severe illness | 14 |
health commission | 14 |
epidemic curve | 14 |
medical staff | 14 |
household transmission | 14 |
data availability | 14 |
prognosis group | 13 |
parainfluenza virus | 13 |
multiple respiratory | 13 |
hand sanitisers | 13 |
year average | 13 |
cov antibodies | 13 |
higher risk | 13 |
confirmed influenza | 13 |
health security | 13 |
convalescent patients | 13 |
virus shedding | 13 |
vaccination coverage | 13 |
nosocomial transmission | 13 |
cases reported | 13 |
statistical analyses | 13 |
cumulative incidence | 13 |
infection episodes | 13 |
mild group | 13 |
disease severity | 13 |
positive samples | 13 |
enveloped viruses | 12 |
isolation time | 12 |
human coronavirus | 12 |
hev seroprevalence | 12 |
data collection | 12 |
secondary cases | 12 |
health measures | 12 |
globally reported | 12 |
increased risk | 12 |
first covid | 12 |
reactive protein | 12 |
preventive measures | 12 |
immune response | 12 |
sentinel surveillance | 12 |
moderate group | 12 |
infected pneumonia | 12 |
infected individuals | 12 |
previous study | 12 |
ebola virus | 12 |
breath samples | 12 |
medical records | 12 |
reported mers | 12 |
general population | 12 |
fatality rates | 12 |
confirmed viral | 12 |
cov transmission | 12 |
zika virus | 12 |
tract infections | 12 |
hospital attendees | 12 |
st july | 11 |
infected patients | 11 |
disease characteristics | 11 |
like illness | 11 |
incidence rate | 11 |
population aged | 11 |
initial infection | 11 |
health emergency | 11 |
generation cases | 11 |
disease burden | 11 |
virus circulation | 11 |
series analysis | 11 |
significantly different | 11 |
sample collection | 11 |
influenza viruses | 11 |
relative risk | 11 |
influenza cases | 11 |
hospital admission | 11 |
coronavirus pneumonia | 11 |
throat swabs | 11 |
recovery rate | 11 |
care unit | 11 |
multiplex pcr | 11 |
influenza pandemic | 11 |
income countries | 11 |
recent study | 11 |
cov infections | 11 |
daily contacts | 11 |
predictive value | 10 |
time pcr | 10 |
time reverse | 10 |
viral nucleic | 10 |
day survival | 10 |
modelling study | 10 |
test results | 10 |
severe patients | 10 |
influenza season | 10 |
asymptomatic infections | 10 |
transmission events | 10 |
cluster cases | 10 |
observational study | 10 |
cardiovascular disease | 10 |
disease surveillance | 10 |
descriptive study | 10 |
disease transmission | 10 |
reproductive number | 10 |
illness episodes | 10 |
case definition | 10 |
considered statistically | 10 |
pao fio | 10 |
performed using | 10 |
faecal samples | 10 |
results showed | 10 |
situation report | 10 |
multiple regression | 10 |
economic status | 10 |
health facility | 10 |
squash hall | 10 |
free country | 10 |
sensitivity analysis | 10 |
several studies | 10 |
emerging infectious | 10 |
knowledge scores | 10 |
sample size | 10 |
virucidal activity | 10 |
healthcare visit | 10 |
clinical outcome | 9 |
test method | 9 |
per million | 9 |
ethical standards | 9 |
contagion rate | 9 |
age children | 9 |
autochthonous case | 9 |
immune system | 9 |
time period | 9 |
gp attendees | 9 |
sports venue | 9 |
worse severity | 9 |
odds ratio | 9 |
underlying medical | 9 |
designated hospitals | 9 |
mortality risk | 9 |
perform hrps | 9 |
nasal throat | 9 |
available data | 9 |
secondary case | 9 |
ari cases | 9 |
days prior | 9 |
hygienic practices | 9 |
virus disease | 9 |
per population | 9 |
respiratory distress | 9 |
endemic country | 9 |
ari incidence | 9 |
blood donors | 9 |
community transmission | 9 |
care homes | 9 |
th march | 9 |
also reported | 9 |
influenza respiratory | 9 |
dressing room | 9 |
significantly associated | 9 |
clinical manifestations | 9 |
positive cases | 9 |
publicly available | 9 |
health system | 9 |
hand rub | 9 |
reverse transcription | 9 |
human rhinovirus | 9 |
medical resources | 9 |
deaths per | 9 |
exact test | 9 |
retrospective cohort | 9 |
control practices | 9 |
contact tracing | 9 |
international spread | 9 |
epidemic curves | 9 |
higher proportion | 9 |
rsv shedding | 9 |
previous mers | 9 |
laboratory findings | 9 |
per day | 9 |
multivariable logistic | 9 |
first cases | 9 |
longitudinal studies | 8 |
surveillance system | 8 |
hev seropositivity | 8 |
global burden | 8 |
virus epidemics | 8 |
local health | 8 |
positive results | 8 |
greater risk | 8 |
educational day | 8 |
data analysis | 8 |
viral interference | 8 |
times higher | 8 |
mechanical ventilation | 8 |
secondary autochthonous | 8 |
early detection | 8 |
travel history | 8 |
camel herds | 8 |
chemical disinfectants | 8 |
person transmission | 8 |
specific grant | 8 |
demographic data | 8 |
future studies | 8 |
female camels | 8 |
elderly care | 8 |
multivariate analysis | 8 |
within households | 8 |
laboratory testing | 8 |
healthcare worker | 8 |
rsv episodes | 8 |
two viruses | 8 |
interquartile range | 8 |
rsv group | 8 |
detection response | 8 |
regression analyses | 8 |
severe pneumonia | 8 |
medical conditions | 8 |
runny nose | 8 |
real time | 8 |
animal reservoir | 8 |
informed consent | 8 |
developed symptoms | 8 |
south korea | 8 |
confirmed mers | 8 |
case detection | 8 |
total population | 8 |
basic reproductive | 8 |
respiratory specimens | 8 |
study included | 8 |
swab specimens | 8 |
average influenza | 8 |
moving average | 8 |
critical group | 8 |
hubei province | 8 |
infected animals | 8 |
came back | 8 |
cov patients | 8 |
spike protein | 8 |
international concern | 8 |
previous season | 8 |
camel population | 8 |
bcg vaccine | 8 |
emergency department | 8 |
swab samples | 8 |
rp patients | 8 |
nosocomial clusters | 8 |
healthcare facilities | 8 |
mild cases | 8 |
arabian peninsula | 8 |
respiratory disease | 8 |
demographic characteristics | 8 |
global pandemic | 8 |
confirmed case | 8 |
univariate analysis | 8 |
st december | 8 |
availability statement | 8 |
ethics committee | 8 |
clinical signs | 8 |
influenza infection | 8 |
symptomatic cases | 8 |
high risk | 8 |
pcr assays | 8 |
present study | 8 |
month period | 8 |
hand washing | 7 |
profit sectors | 7 |
throat swab | 7 |
results revealed | 7 |
healthcare services | 7 |
authors declare | 7 |
centred moving | 7 |
body temperature | 7 |
university community | 7 |
genomic data | 7 |
hygienic practice | 7 |
diabetes mellitus | 7 |
blood urea | 7 |
final model | 7 |
negative binomial | 7 |
various risk | 7 |
high influenza | 7 |
high rates | 7 |
igg antibodies | 7 |
also found | 7 |
first reported | 7 |
healthcare system | 7 |
viral illness | 7 |
nucleic acids | 7 |
mild symptoms | 7 |
fibre streak | 7 |
commonly used | 7 |
human infections | 7 |
performing hrps | 7 |
overall ghsi | 7 |
research studies | 7 |
epidemiological curve | 7 |
time difference | 7 |
data available | 7 |
vulnerable populations | 7 |
health authorities | 7 |
nrp adult | 7 |
continuously vaccinated | 7 |
south asia | 7 |
multiple linear | 7 |
obstructive pulmonary | 7 |
latent individuals | 7 |
nasopharyngeal swabs | 7 |
study design | 7 |
high proportion | 7 |
phylogenetic analysis | 7 |
experimental infection | 7 |
acquired pneumonia | 7 |
epidemiological investigation | 7 |
infection prevention | 7 |
protective equipment | 7 |
small number | 7 |
closely related | 7 |
corresponding author | 7 |
increasing age | 7 |
distress syndrome | 7 |
disease prevention | 7 |
large number | 7 |
even though | 7 |
healthcare settings | 7 |
elderly patients | 7 |
one secondary | 7 |
case definitions | 7 |
asymptomatic infection | 7 |
infected camels | 7 |
clusters identified | 7 |
cov case | 7 |
significant association | 7 |
viral co | 7 |
clinical trials | 7 |
knowledge score | 7 |
patients without | 7 |
positivity rate | 7 |
time rt | 7 |
recent studies | 7 |
infection among | 7 |
camel herd | 7 |
early stages | 7 |
chronic obstructive | 7 |
time points | 7 |
significant predictors | 7 |
mental health | 7 |
western european | 7 |
diagnostic data | 7 |
binomial regression | 7 |
three family | 7 |
high prevalence | 7 |
population size | 7 |
auxiliary variables | 7 |
human cases | 7 |
bacterial infection | 7 |
hygienic hand | 7 |
streak shadow | 7 |
cell count | 7 |
age structure | 7 |
ordinal logistic | 7 |
study also | 7 |
supportive care | 7 |
case report | 7 |
per cent | 7 |
confidence intervals | 6 |
underlying diseases | 6 |
emerging pathogens | 6 |
advisory committee | 6 |
illness group | 6 |
individual level | 6 |
health workers | 6 |
roc curve | 6 |
clinical presentation | 6 |
cases per | 6 |
surveillance data | 6 |
illness among | 6 |
cumulative cases | 6 |
transmission patterns | 6 |
electronic medical | 6 |
much higher | 6 |
risk groups | 6 |
several limitations | 6 |
identified clusters | 6 |
vaccination status | 6 |
study shows | 6 |
log transformed | 6 |
interim guidance | 6 |
early days | 6 |
early outbreak | 6 |
population level | 6 |
infectious virus | 6 |
distal large | 6 |
antiviral drugs | 6 |
algebraic equations | 6 |
hand rubs | 6 |
influenza activity | 6 |
medically attended | 6 |
cov epidemic | 6 |
study reported | 6 |
patient population | 6 |
one health | 6 |
underlying conditions | 6 |
general hospital | 6 |
cluster analysis | 6 |
hev rna | 6 |
literature review | 6 |
ill group | 6 |
factors affecting | 6 |
log reduction | 6 |
blood samples | 6 |
patients aged | 6 |
tract infection | 6 |
good prognosis | 6 |
may also | 6 |
million cases | 6 |
may provide | 6 |
union hospital | 6 |
clinical case | 6 |
first days | 6 |
see table | 6 |
two mortality | 6 |
imported camels | 6 |
testing positive | 6 |
sars epidemic | 6 |
median seroprevalence | 6 |
lymphocyte count | 6 |
new york | 6 |
secondary infections | 6 |
ecologic studies | 6 |
outbreak period | 6 |
virus type | 6 |
hospitalized children | 6 |
rsv transmission | 6 |
human infection | 6 |
health systems | 6 |
respiratory pathogens | 6 |
sars coronavirus | 6 |
clinical data | 6 |
ghsi score | 6 |
mean age | 6 |
common symptoms | 6 |
shedding patterns | 6 |
west african | 6 |
infection fatality | 6 |
large intestinal | 6 |
urea nitrogen | 6 |
hev infection | 6 |
suspected patients | 6 |
funding agency | 6 |
young infants | 6 |
curve analysis | 6 |
newly vaccinated | 6 |
like symptoms | 6 |
independent risk | 6 |
erinaceus europaeus | 6 |
home country | 6 |
hev antibodies | 6 |
creatine kinase | 6 |
serum albumin | 6 |
first time | 6 |
days later | 6 |
cov shedding | 6 |
cox proportional | 6 |
rsv infections | 6 |
better understand | 6 |
hand disinfection | 6 |
day mortality | 6 |
vaccination history | 6 |
ari symptoms | 6 |
intestinal tract | 6 |
mainland china | 6 |
also showed | 6 |
converting enzyme | 6 |
timely manner | 6 |
day conference | 6 |
pulmonary disease | 6 |
model parameters | 6 |
scoring system | 6 |
among patients | 6 |
driven analysis | 6 |
lessons learned | 6 |
data generated | 6 |
based study | 6 |
seroprevalence rates | 6 |
acute lower | 6 |
toward infection | 6 |
study aimed | 6 |
geographic spread | 6 |
clinical disease | 6 |
samples collected | 6 |
healthcare personnel | 6 |
average number | 6 |
clinical trial | 6 |
mers cases | 6 |
transmission within | 6 |
multivariate sensitivity | 6 |
prediction model | 6 |
review board | 6 |
perceived adequacy | 6 |
previously described | 6 |
communicable diseases | 6 |
throat specimens | 6 |
real data | 6 |
multiple organ | 6 |
statistical differences | 5 |
limited data | 5 |
response time | 5 |
severe outcomes | 5 |
care units | 5 |
human samples | 5 |
tier source | 5 |
inverse care | 5 |
visited country | 5 |
missing values | 5 |
repeat infections | 5 |
surveillance systems | 5 |
studies investigating | 5 |
hospital beds | 5 |
organ failure | 5 |
date reported | 5 |
avian influenza | 5 |
vaccination campaigns | 5 |
different groups | 5 |
air travel | 5 |
reduce mortality | 5 |
old group | 5 |
disease epidemiology | 5 |
cov circulation | 5 |
retrospective analysis | 5 |
measures taken | 5 |
systematic analysis | 5 |
neutrophil count | 5 |
deaths million | 5 |
quarantine facilities | 5 |
frequently detected | 5 |
medical masks | 5 |
survival rate | 5 |
lung lobes | 5 |
epidemiological characteristics | 5 |
innate immune | 5 |
viruses may | 5 |
another study | 5 |
pcr testing | 5 |
healthcare systems | 5 |
health preparedness | 5 |
institutional review | 5 |
sars patients | 5 |
muscle pain | 5 |
high incidence | 5 |
hev igg | 5 |
global spread | 5 |
direct contact | 5 |
disease exportation | 5 |
chronic diseases | 5 |
ncov outbreak | 5 |
pandemic preparedness | 5 |
research projects | 5 |
incident cases | 5 |
influenza strains | 5 |
sectional survey | 5 |
nine animals | 5 |
dual respiratory | 5 |
household illness | 5 |
vaccine uptake | 5 |
reported covid | 5 |
negative trend | 5 |
clinical samples | 5 |
higher knowledge | 5 |
personal protective | 5 |
heart disease | 5 |
assess whether | 5 |
infected people | 5 |
factors influencing | 5 |
nasopharyngeal swab | 5 |
deaths due | 5 |
importation risk | 5 |
several factors | 5 |
elderly individuals | 5 |
designated hospital | 5 |
emerging viruses | 5 |
inflammatory response | 5 |
cvd mortality | 5 |
current covid | 5 |
one study | 5 |
study suggests | 5 |
low birthweight | 5 |
two studies | 5 |
clinical outcomes | 5 |
clinical severity | 5 |
ebola epidemic | 5 |
prospective cohort | 5 |
among hcws | 5 |
mortality associated | 5 |
estimated population | 5 |
pregnant women | 5 |
among health | 5 |
discharge criteria | 5 |
cox regression | 5 |
multivariable analysis | 5 |
virus groups | 5 |
int csr | 5 |
study aims | 5 |
attitudes toward | 5 |
analysed using | 5 |
determine whether | 5 |
close contacts | 5 |
wildlife centres | 5 |
previous experience | 5 |
lymphocyte subsets | 5 |
central hospital | 5 |
corona virus | 5 |
respiratory illnesses | 5 |
indian subcontinent | 5 |
controlled trial | 5 |
pdm virus | 5 |
oropharyngeal swab | 5 |
camel contact | 5 |
german ericov | 5 |
multivariate logistic | 5 |
data sources | 5 |
symptomatic patients | 5 |
trend component | 5 |
rate ratio | 5 |
samples obtained | 5 |
study conducted | 5 |
six parameters | 5 |
human health | 5 |
infected dromedary | 5 |
virus group | 5 |
king saud | 5 |
infection episode | 5 |
cytokine storm | 5 |
significant negative | 5 |
middle eastern | 5 |
hand sanitizers | 5 |
seasonality component | 5 |
information regarding | 5 |
care facilities | 5 |
analysis showed | 5 |
research received | 5 |
personal vulnerability | 5 |
infected traveller | 5 |
familial cluster | 5 |
contingency plans | 5 |
infections due | 5 |
isolation wards | 5 |
myocardial injury | 5 |
higher number | 5 |
hospitalised patients | 5 |
virus co | 5 |
based surveillance | 5 |
human populations | 5 |
measures implemented | 5 |
united kingdom | 5 |
study participants | 5 |
murine norovirus | 5 |
statistical analysis | 5 |
leading cause | 5 |
surveillance study | 5 |
west africa | 5 |
control study | 5 |
including fever | 5 |
severe respiratory | 5 |
contact time | 5 |
including age | 5 |
practice scores | 5 |
competing interests | 5 |
health locus | 5 |
three cases | 5 |
worry levels | 5 |
health resources | 5 |
may help | 5 |
rural nepal | 5 |
pcr test | 5 |
response efforts | 5 |
healthcare utilization | 5 |
severe symptoms | 5 |
ng ml | 5 |
case finding | 5 |
genome sequencing | 5 |
immune responses | 5 |
active surveillance | 5 |
disease study | 5 |
hand wash | 5 |
household clusters | 5 |
household characteristics | 5 |
rate among | 5 |
bacterial infections | 5 |
healthcare visits | 5 |
even death | 5 |
infectious individuals | 5 |
sensitivity analyses | 5 |
death rate | 5 |
rural kenya | 5 |
disease spread | 5 |
hand disinfectants | 5 |
transcription polymerase | 5 |
deceased patients | 5 |
respiratory failure | 5 |
high case | 5 |
community study | 5 |
african countries | 5 |
two communities | 5 |
fever resolution | 5 |
ct scans | 5 |
severe coronavirus | 5 |
disease progression | 5 |
asymptomatic individuals | 5 |
studies suggest | 5 |
among covid | 5 |
test positive | 5 |
treatment days | 5 |
international health | 5 |
single variable | 5 |
elevated nlr | 5 |
symptom score | 5 |
odds ratios | 5 |
health surveillance | 4 |
aged year | 4 |
serum samples | 4 |
infection within | 4 |
investigated using | 4 |
disease coronavirus | 4 |
global mers | 4 |
influenza transmission | 4 |
infection patterns | 4 |
bacillus calmette | 4 |
multivariate ordinal | 4 |
dhaka tribune | 4 |
natural reservoir | 4 |
external evaluation | 4 |
decision making | 4 |
tested nasal | 4 |
although influenza | 4 |
epidemiological link | 4 |
patients admitted | 4 |
worry level | 4 |
educational campaigns | 4 |
specific antibodies | 4 |
shahroud county | 4 |
viral detection | 4 |
well documented | 4 |
critical covid | 4 |
first confirmed | 4 |
study date | 4 |
molecular epidemiology | 4 |
death counts | 4 |
assessed contributions | 4 |
adult inpatients | 4 |
ili cases | 4 |
virus detection | 4 |
normally distributed | 4 |
qualified nurses | 4 |
additional information | 4 |
longer shedding | 4 |
serological evidence | 4 |
fio ratio | 4 |
receiver operating | 4 |
security index | 4 |
vaccine development | 4 |
ill covid | 4 |
significant predictor | 4 |
life expectancy | 4 |
response rate | 4 |
specific antiviral | 4 |
population groups | 4 |
positive specimens | 4 |
virus respiratory | 4 |
sars outbreak | 4 |
epidemic spread | 4 |
lobes involved | 4 |
operating characteristic | 4 |
male camels | 4 |
vaccination uptake | 4 |
step cluster | 4 |
author orcids | 4 |
mini kit | 4 |
molecular surveillance | 4 |
statistical significance | 4 |
following criteria | 4 |
international spreading | 4 |
risk procedures | 4 |
research council | 4 |
patients attending | 4 |
genome sequence | 4 |
detection rate | 4 |
powerful others | 4 |
versus single | 4 |
respiratory season | 4 |
tested patients | 4 |
platelet count | 4 |
income nations | 4 |
histopathological examination | 4 |
full genome | 4 |
may explain | 4 |
positive specimen | 4 |
camelus dromedarius | 4 |
white blood | 4 |
technical appendix | 4 |
month study | 4 |
correlation coefficient | 4 |
may result | 4 |
four family | 4 |
dengue virus | 4 |
negative samples | 4 |
bactrian camels | 4 |
arabia middle | 4 |
previously published | 4 |
analysis revealed | 4 |
whole sample | 4 |
significant correlation | 4 |
trend components | 4 |
higher levels | 4 |
seasonal variations | 4 |
first report | 4 |
future research | 4 |
samples tested | 4 |
mobile hospitals | 4 |
mixing patterns | 4 |
current knowledge | 4 |
three indicators | 4 |
rural areas | 4 |
population density | 4 |
psychological impact | 4 |
asymptomatic respiratory | 4 |
chronic kidney | 4 |
fever virus | 4 |
early transmission | 4 |
laboratory indexes | 4 |
source population | 4 |
asymptomatic carriers | 4 |
laboratory indicators | 4 |
local population | 4 |
epidemiological history | 4 |
camel samples | 4 |
mathematical models | 4 |
age distribution | 4 |
asymptomatic according | 4 |
respiratory pathogen | 4 |
negative associations | 4 |
acute infectious | 4 |
episodes occurred | 4 |
respiratory system | 4 |
predict covid | 4 |
virus seroprevalence | 4 |
series analyses | 4 |
illness clusters | 4 |
missing data | 4 |
group showed | 4 |
two weeks | 4 |
low hev | 4 |
european centre | 4 |
study clinical | 4 |
oxygen saturation | 4 |
randomised controlled | 4 |
information system | 4 |
telephone calls | 4 |
ericov infection | 4 |
regression coefficient | 4 |
may lead | 4 |
following symptoms | 4 |
neutrophil counts | 4 |
medical college | 4 |
population group | 4 |
household surveillance | 4 |
pcr assay | 4 |
across patient | 4 |
care settings | 4 |
adults without | 4 |
countries reporting | 4 |
specimen collection | 4 |
tertiary care | 4 |
symptomatic individuals | 4 |
peripheral blood | 4 |
rank test | 4 |
suspected repeat | 4 |
community facilities | 4 |
emergency departments | 4 |
cycle threshold | 4 |
calculated using | 4 |
drying time | 4 |
vaccination rates | 4 |
expected number | 4 |
virus prevalence | 4 |
studies show | 4 |
symptomatic infection | 4 |
household cohort | 4 |
environmental factors | 4 |
blood count | 4 |
greater proportion | 4 |
strongly correlated | 4 |
susceptible population | 4 |
four groups | 4 |
medical research | 4 |
hospital setting | 4 |
patients presenting | 4 |
influenza disease | 4 |
early diagnosis | 4 |
infected patient | 4 |
disease course | 4 |
among camels | 4 |
auxiliary variable | 4 |
underlying ecological | 4 |
medical care | 4 |
global alert | 4 |
us study | 4 |
organ dysfunction | 4 |
institute inc | 4 |
towards influenza | 4 |
high burden | 4 |
care law | 4 |
using standard | 4 |
hedgehog samples | 4 |
critical cases | 4 |
fatality ratio | 4 |
contact rate | 4 |
wuhan university | 4 |
analysis using | 4 |
different age | 4 |
saharan africa | 4 |
diagnostic tests | 4 |
infection overall | 4 |
individual viruses | 4 |
transmission occurred | 4 |
commonly detected | 4 |
animal markets | 4 |
blood cell | 4 |
hev genotypes | 4 |
past days | 4 |
strongly associated | 4 |
higher seroprevalence | 4 |
independent determinants | 4 |
highest risk | 4 |
related mortality | 4 |
multivariable model | 4 |
study author | 4 |
symptom severity | 4 |
rural south | 4 |
laboratory parameters | 4 |
sampling interval | 4 |
selection bias | 4 |
two complementary | 4 |
better compliance | 4 |
cumulative logit | 4 |
tongji medical | 4 |
community spread | 4 |
digestive system | 4 |
three index | 4 |
symptom scores | 4 |
arabia mers | 4 |
cardiovascular diseases | 4 |
total cases | 4 |
discharged patients | 4 |
higher odds | 4 |
mortality among | 4 |
drying times | 4 |
mildly symptomatic | 4 |
rapidly spread | 4 |
serum creatinine | 4 |
data used | 4 |
multivariate regression | 4 |
hill function | 4 |
independent variables | 4 |
population age | 4 |
single virus | 4 |
following conditions | 4 |
partial mers | 4 |
lassa fever | 4 |
acid testing | 4 |
two diseases | 4 |
early phase | 4 |
simple regression | 4 |
systemic symptoms | 4 |
virus load | 4 |
china date | 4 |
zoonotic niche | 4 |
laboratory examination | 4 |
findings times | 4 |
care wards | 4 |
european hedgehog | 4 |
complete genome | 4 |
cigarette smoking | 4 |
reasonable request | 4 |
pandemic era | 4 |
european hedgehogs | 4 |
older children | 4 |
epidemiological analysis | 4 |
patients died | 4 |
coastal kenya | 4 |
study found | 4 |
vaccination decisions | 4 |
absolute agreement | 4 |
global reported | 4 |
planning considerations | 4 |
pandemic will | 4 |
human coronaviruses | 4 |
infections within | 4 |
higher mortality | 4 |
study population | 4 |
hmpv infections | 4 |
positive hedgehogs | 4 |
antibodies detection | 4 |
seasonal peaks | 4 |
risk perceptions | 4 |
small sample | 4 |
antibiotic therapy | 4 |
democratic republic | 4 |
emergency response | 4 |
median time | 4 |
analysis clinical | 4 |
less common | 4 |
treatment protocol | 4 |
patient care | 4 |
strongly recommend | 4 |
neutralizing antibodies | 4 |
age category | 4 |
potential role | 4 |
johns hopkins | 4 |
occurred indirectly | 4 |
infectiousness period | 4 |
sierra leone | 4 |
patient subgroups | 4 |
case reported | 4 |
epidemiology infection | 4 |
coronavirus indicating | 4 |
immune cells | 4 |
transport media | 4 |
randomized clinical | 4 |
statistical difference | 4 |
zhongnan hospital | 4 |
indirect transmission | 4 |
shows limits | 4 |
nigeria centre | 4 |
different countries | 4 |
transmission potential | 4 |
health services | 4 |
kidney disease | 4 |
patients showed | 4 |
worth noting | 4 |
drug administration | 4 |
negative results | 4 |
positive rate | 4 |
randomly selected | 4 |
distancing measures | 4 |
sas institute | 4 |
wuhan city | 4 |
last days | 4 |
hand sanitizer | 4 |
findings suggest | 4 |
cases may | 4 |
aggregated data | 4 |
rapid increase | 4 |
camel populations | 4 |
ericov status | 4 |
using sas | 4 |
four cases | 4 |
without symptoms | 4 |
underlying growth | 4 |
negative association | 4 |
protective hygienic | 4 |
health regulations | 4 |
global mortality | 4 |
mandatory vaccination | 4 |
extracted rna | 4 |
dry cough | 4 |
latent patients | 4 |
one respiratory | 4 |
timely isolation | 4 |
sectional study | 4 |
infections among | 4 |
perception score | 4 |
control strategies | 4 |
higher neutrophil | 4 |
health organisation | 4 |
epidemiological models | 4 |
exposure history | 4 |
virus outbreak | 4 |
fever clinic | 4 |
monthly global | 4 |
among different | 4 |
preparedness scores | 4 |
cov clusters | 4 |
prevention strategies | 4 |
examination results | 4 |
one case | 4 |
index patient | 4 |
hedgehog population | 4 |
two distinct | 4 |
situations like | 4 |
different respiratory | 4 |
systemic inflammation | 4 |
incubation time | 4 |
mean difference | 4 |
hand disinfectant | 4 |
body condition | 4 |
importing risk | 4 |
south africa | 4 |
isolation ward | 4 |
viral pneumonia | 4 |
contracting influenza | 4 |
sporadic patients | 4 |
symptomatic infections | 4 |
median duration | 4 |
cause severe | 4 |
driven research | 4 |
pleural thickening | 4 |
disease outbreaks | 4 |
better understanding | 4 |
playing squash | 4 |
least three | 4 |
computed tomography | 4 |
vaccination intent | 4 |
risk simulations | 4 |
study estimated | 4 |
virus spread | 4 |
another respiratory | 4 |
joint external | 4 |
airborne transmission | 4 |
respiratory rate | 4 |
transmission chains | 3 |
pathogenic human | 3 |
burkina faso | 3 |
one episode | 3 |
provide insight | 3 |
average crude | 3 |
remains unclear | 3 |
laboratory test | 3 |
median days | 3 |
epithelial cells | 3 |
novel clade | 3 |
generation sequencing | 3 |
crude case | 3 |
mortality due | 3 |
camel breeding | 3 |
early warning | 3 |
negative consequences | 3 |
death toll | 3 |
dhabi emirate | 3 |
asymptomatic patients | 3 |
without bcg | 3 |
daily basis | 3 |
archive disease | 3 |
bred camels | 3 |
seroprevalence among | 3 |
ecologic fallacy | 3 |
coronavirus sars | 3 |
epidemic peaks | 3 |
original series | 3 |
regression results | 3 |
chinese medicine | 3 |
sick per | 3 |
cases linked | 3 |
longitudinal study | 3 |
study used | 3 |
medical students | 3 |
dilution series | 3 |
huazhong university | 3 |
ed visits | 3 |
per unit | 3 |
four major | 3 |
seventh edition | 3 |
conditions must | 3 |
unvaccinated nurses | 3 |
vaccination rate | 3 |
among symptomatic | 3 |
transmission data | 3 |
liver injury | 3 |
case reports | 3 |
fever duration | 3 |
difference among | 3 |
care ward | 3 |
predicting influenza | 3 |
observed episodes | 3 |
among dromedary | 3 |
significantly elevated | 3 |
may occur | 3 |
bavarian state | 3 |
eurostat database | 3 |
poorly understood | 3 |
low risk | 3 |
epidemic preparedness | 3 |
research groups | 3 |
face masks | 3 |
medical area | 3 |
viral transmission | 3 |
seasonal epidemics | 3 |
source data | 3 |
eastern respiratory | 3 |
may differ | 3 |
greatest incidence | 3 |
bat coronaviruses | 3 |
disease onset | 3 |
research idea | 3 |
disease clinical | 3 |
country comparisons | 3 |
cough within | 3 |
sars epidemics | 3 |
transmission risk | 3 |
detected viruses | 3 |
two countries | 3 |
antiviral treatment | 3 |
prospective study | 3 |
economic impact | 3 |
future educational | 3 |
gross pme | 3 |
local level | 3 |
rhode island | 3 |
funding agencies | 3 |
per travellers | 3 |
health agency | 3 |
outbreak investigation | 3 |
five differential | 3 |
multiple versus | 3 |
outbreak originating | 3 |
oropharyngeal swabs | 3 |
secondary healthcare | 3 |
information available | 3 |
cov infected | 3 |
eight auxiliary | 3 |
local beer | 3 |
human development | 3 |
hazard risk | 3 |
new infections | 3 |
collect data | 3 |
cov may | 3 |
critical patients | 3 |
studies also | 3 |
comprehensive study | 3 |
individual faculty | 3 |
lancet infectious | 3 |
hcws performing | 3 |
ct signs | 3 |
valuable information | 3 |
clinical management | 3 |
outside china | 3 |
three factors | 3 |
saud bin | 3 |
pneumonia mortality | 3 |
north america | 3 |
rna rp | 3 |
suspected sars | 3 |
average score | 3 |
virus watch | 3 |
independent factors | 3 |
differences across | 3 |
done using | 3 |
infected travellers | 3 |
clinical respiratory | 3 |
ct examination | 3 |
respiratory wards | 3 |
stata corp | 3 |
accumulated knowledge | 3 |
health sciences | 3 |
inanimate surfaces | 3 |
disease importation | 3 |
author contributions | 3 |
substantial morbidity | 3 |
primary case | 3 |
developing worse | 3 |
measuring disease | 3 |
positive rna | 3 |
may indicate | 3 |
adult camels | 3 |
generation patients | 3 |
limited medical | 3 |
surgical hand | 3 |
critical role | 3 |
symptomatic status | 3 |
based research | 3 |
disease prevalence | 3 |
sodium hydroxide | 3 |
previous days | 3 |
studies found | 3 |
epidemics occurred | 3 |
sarlahi district | 3 |
countries showed | 3 |
recommended formulations | 3 |
southern nepal | 3 |
nasal swab | 3 |
individuals contacted | 3 |
asymptomatic ratio | 3 |
reporting symptoms | 3 |
respiratory droplets | 3 |
using stata | 3 |
chinese center | 3 |
without clinical | 3 |
prevent respiratory | 3 |
wbc count | 3 |
see supplementary | 3 |
human interface | 3 |
one limitation | 3 |
cases will | 3 |
contact history | 3 |
identify factors | 3 |
health control | 3 |
breeding season | 3 |
vaccine effectiveness | 3 |
neutrophillymphocyte ratio | 3 |
poisson regression | 3 |
hcw attitudes | 3 |
outbreak epicentre | 3 |
local camels | 3 |
clinics emerged | 3 |
epidemiological studies | 3 |
infection status | 3 |
study may | 3 |
variable analysis | 3 |
years age | 3 |
us adults | 3 |
reporting cases | 3 |
pandemic period | 3 |
given infection | 3 |
statistical interactions | 3 |
two cases | 3 |
tests per | 3 |
respiratory abnormalities | 3 |
infections occurring | 3 |
coronavirus detection | 3 |
strategies will | 3 |
temporary immunity | 3 |
new coronavirus | 3 |
spss version | 3 |
higher scores | 3 |
asymptomatic transmission | 3 |
dead patients | 3 |
described previously | 3 |
average population | 3 |
within families | 3 |
infective contact | 3 |
response times | 3 |
childcare attendees | 3 |
epidemiological data | 3 |
wide burden | 3 |
pcr products | 3 |
winter months | 3 |
strongest predictor | 3 |
abdulaziz university | 3 |
nipah virus | 3 |
written informed | 3 |
medical healthcare | 3 |
mathematical modelling | 3 |
medical visits | 3 |
marshfield clinic | 3 |
wuhan union | 3 |
patient age | 3 |
detailed data | 3 |
model assumes | 3 |
special administrative | 3 |
least days | 3 |
ct imaging | 3 |
two different | 3 |
among individuals | 3 |
testing using | 3 |
infection rate | 3 |
epidemiological evidence | 3 |
factor affecting | 3 |
probably due | 3 |
previous uk | 3 |
independent predictor | 3 |
considered significant | 3 |
cov replication | 3 |
strongly predicted | 3 |
powerful tool | 3 |
help explain | 3 |
events per | 3 |
medical team | 3 |
first pair | 3 |
primary outcomes | 3 |
research study | 3 |
hrv transmission | 3 |
high crude | 3 |
positive tests | 3 |
physical activity | 3 |
count percentage | 3 |
patients hospitalized | 3 |
aquatic birds | 3 |
importing covid | 3 |
health board | 3 |
coronavirus outbreak | 3 |
vaccination among | 3 |
data collected | 3 |
prevalence curve | 3 |
commonly isolated | 3 |
partial lockdown | 3 |
epidemiological consequences | 3 |
nasopharyngeal aspirates | 3 |
nine respiratory | 3 |
previous work | 3 |
ongoing mers | 3 |
urban areas | 3 |
preliminary estimation | 3 |
lipid membrane | 3 |
three clusters | 3 |
arabia evidence | 3 |
significant statistical | 3 |
disease caused | 3 |
indicating person | 3 |
college station | 3 |
vaccinated group | 3 |
disease duration | 3 |
front line | 3 |
mean duration | 3 |
lower lymphocyte | 3 |
routine diagnostic | 3 |
present data | 3 |
two indices | 3 |
microsoft excel | 3 |
risk compared | 3 |
infection risk | 3 |
individuals infected | 3 |
lower levels | 3 |
transportation links | 3 |
healthy people | 3 |
assessed using | 3 |
phylogenetic analyses | 3 |
sampling frame | 3 |
accession number | 3 |
rapid response | 3 |
higher mers | 3 |
one patient | 3 |
biological systems | 3 |
green faeces | 3 |
plausible futures | 3 |
symptom criteria | 3 |
cov cluster | 3 |
patient factors | 3 |
disease associated | 3 |
clusterassociated cases | 3 |
early epidemic | 3 |
cov outbreaks | 3 |
associated cases | 3 |
hospital outbreak | 3 |
initial viral | 3 |
spss inc | 3 |
increased significantly | 3 |
arab emirates | 3 |
positive camels | 3 |
pme findings | 3 |
raises possibility | 3 |
children attending | 3 |
incident infection | 3 |
results demonstrated | 3 |
critical review | 3 |
restrictions apply | 3 |
declared covid | 3 |
current status | 3 |
household member | 3 |
relatively frequently | 3 |
scenario planning | 3 |
epidemic peak | 3 |
attitude scores | 3 |
health risks | 3 |
higher stress | 3 |
highly sensitive | 3 |
ethics review | 3 |
vaccinated cluster | 3 |
different time | 3 |
many cities | 3 |
mild patients | 3 |
virus via | 3 |
hcws working | 3 |
lagos state | 3 |
closely correlated | 3 |
early identification | 3 |
vulnerable groups | 3 |
viral rnas | 3 |
infection outcomes | 3 |
shanghai city | 3 |
patient episodes | 3 |
rolling cross | 3 |
various district | 3 |
generating procedures | 3 |
chest pain | 3 |
family member | 3 |
commonly reported | 3 |
testing data | 3 |
distance measures | 3 |
pneumonia associated | 3 |
increased knowledge | 3 |
local transmission | 3 |
ethical approval | 3 |
data quality | 3 |
research articles | 3 |
low viral | 3 |
higher perceived | 3 |
community level | 3 |
median range | 3 |
circulation patterns | 3 |
unadjusted odds | 3 |
hev positive | 3 |
african ebola | 3 |
mandatory influenza | 3 |
likely due | 3 |
residential setting | 3 |
whole genome | 3 |
professional management | 3 |
data using | 3 |
sleep improvement | 3 |
review committee | 3 |
medical centre | 3 |
lower survival | 3 |
first observed | 3 |
among adults | 3 |
hedgehogs sampled | 3 |
attending daycare | 3 |
one underlying | 3 |
species transmission | 3 |
geographical regions | 3 |
respiratory monitoring | 3 |
proportional hazards | 3 |
specimens within | 3 |
allowed us | 3 |
five states | 3 |
clinical significance | 3 |
reported association | 3 |
poisson distribution | 3 |
related healthcare | 3 |
different types | 3 |
lactate dehydrogenase | 3 |
remained unchanged | 3 |
coronavirus species | 3 |
findings may | 3 |
facility registry | 3 |
data point | 3 |
differ significantly | 3 |
based control | 3 |
million deaths | 3 |
optimization process | 3 |
attended ari | 3 |
saudi arabian | 3 |
ecological determinants | 3 |
jee scoring | 3 |
older adults | 3 |
probably explained | 3 |
hospital stay | 3 |
one hrp | 3 |
relatively small | 3 |
viruses associated | 3 |
although mers | 3 |
censored episodes | 3 |
virus replication | 3 |
potential value | 3 |
york city | 3 |
armed forces | 3 |
prevent human | 3 |
contingency planning | 3 |
individual virus | 3 |
symptoms within | 3 |
novel betacoronavirus | 3 |
also confirmed | 3 |
influenza deaths | 3 |
time unit | 3 |
three time | 3 |
recent systematic | 3 |
patients received | 3 |
may well | 3 |
largest number | 3 |
contaminated objects | 3 |
rapid screening | 3 |
time periods | 3 |
involving patients | 3 |
nasal congestion | 3 |
chikungunya virus | 3 |
severely ill | 3 |
prolonged viral | 3 |
reaction assay | 3 |
logit model | 3 |
robert koch | 3 |
aged patients | 3 |
system plays | 3 |
developed severe | 3 |
multiple years | 3 |
across multiple | 3 |
individuals per | 3 |
adults aged | 3 |
telephone interviews | 3 |
medical shelter | 3 |
highest proportion | 3 |
adjusted life | 3 |
daily incidence | 3 |
parainfluenza viruses | 3 |
reproduction numbers | 3 |
rsv season | 3 |
transmission chain | 3 |
likelihood value | 3 |
disease will | 3 |
risk associated | 3 |
viral gene | 3 |
similar results | 3 |
standard deviation | 3 |
two clusters | 3 |
multiple countries | 3 |
awareness campaigns | 3 |
large numbers | 3 |
simulation output | 3 |
four hospitals | 3 |
findings indicate | 3 |
influenza infections | 3 |
clinical risk | 3 |
potential risk | 3 |
perception scores | 3 |
high cfr | 3 |
uncertainties mean | 3 |
per time | 3 |
among children | 3 |
daily cases | 3 |
influencing factors | 3 |
hospitals since | 3 |
wildlife populations | 3 |
kong sars | 3 |
new framework | 3 |
crucial role | 3 |
sought medical | 3 |
first line | 3 |
convalescence period | 3 |
dynamic model | 3 |
septic shock | 3 |
countries across | 3 |
available evidence | 3 |
patient origin | 3 |
across borders | 3 |
economic activities | 3 |
verbal consent | 3 |
study methods | 3 |
based determinants | 3 |
workforce capacity | 3 |
inadequate testing | 3 |
potentially infective | 3 |
mainland europe | 3 |
multivariable regression | 3 |
hall number | 3 |
occupational health | 3 |
following initial | 3 |
different severity | 3 |
surveillance strategies | 3 |
tract contents | 3 |
unknown aetiology | 3 |
recommended groups | 3 |
model output | 3 |
findings showed | 3 |
superspreading events | 3 |
hcws performed | 3 |
adults may | 3 |
rsv episode | 3 |
special issue | 3 |
around million | 3 |
treatment outcomes | 3 |
camel sera | 3 |
daily contact | 3 |
weekly incidence | 3 |
shed virus | 3 |
iterative process | 3 |
study revealed | 3 |
protect vulnerable | 3 |
hospital hcws | 3 |
global public | 3 |
symptomatic persons | 3 |
estimated using | 3 |
first day | 3 |
significantly older | 3 |
time polymerase | 3 |
influenza epidemics | 3 |
new data | 3 |
highly infectious | 3 |
tract samples | 3 |
droplet transmission | 3 |
data reported | 3 |
research foundation | 3 |
collected nasal | 3 |
antibody levels | 3 |
prevention measures | 3 |
conducted using | 3 |
without fever | 3 |
single centre | 3 |
risk group | 3 |
viral pathogens | 3 |
generations within | 3 |
primary infection | 3 |
comparison among | 3 |
jin yin | 3 |
case series | 3 |
neutralising antibodies | 3 |
clinics distributed | 3 |
medical chart | 3 |
distributed continuous | 3 |
administrative region | 3 |
infections en | 3 |
multiple viruses | 3 |
health authority | 3 |
faecal sample | 3 |
kong special | 3 |
random sampling | 3 |
suspected covid | 3 |
attack rates | 3 |
based studies | 3 |
times greater | 3 |
report higher | 3 |
influenza prevention | 3 |
situation reports | 3 |
samples positive | 3 |
three groups | 3 |
healthcare burden | 3 |
monroe county | 3 |
immune function | 3 |
risk quartile | 3 |
clinical illness | 3 |
two nasopharyngeal | 3 |
across countries | 3 |
minor clinical | 3 |
priority diseases | 3 |
bacterial pneumonia | 3 |
across gb | 3 |
respiratory protection | 3 |
will unfold | 3 |
one single | 3 |
young age | 3 |
health planning | 3 |
model fit | 3 |
previous estimates | 3 |
temporal dynamics | 3 |
district areas | 3 |
air pollution | 3 |
spread rapidly | 3 |
respiratory infectious | 3 |
hospital death | 3 |
mild disease | 3 |
different viruses | 3 |
abu dhabi | 3 |
viral transport | 3 |
among confirmed | 3 |
diagnostic capacity | 3 |
africa ebola | 3 |
health department | 3 |
last years | 3 |
geographic origin | 3 |
susceptible individuals | 3 |
also observed | 3 |
human resources | 3 |
seasonal outbreaks | 3 |
viruses circulating | 3 |
case numbers | 3 |
low rates | 3 |
clinically relevant | 3 |
differential diagnosis | 3 |
acid detection | 3 |
laboratory confirmation | 3 |
highest number | 3 |
states plus | 3 |
using spss | 3 |
winter season | 3 |
cases imported | 3 |
wide surveillance | 3 |
make predictions | 3 |
virucidal efficacy | 3 |
aspartate aminotransferase | 3 |
nigeria health | 3 |
nine viruses | 3 |
global number | 3 |
time taken | 3 |
medical record | 3 |
descriptive analysis | 3 |
disease outcomes | 3 |
spreading events | 3 |
lag calculated | 3 |
positive patients | 3 |
crude cfr | 3 |
illness caused | 3 |
laboratory data | 3 |
important factor | 3 |
tissue preservation | 3 |
trial version | 3 |
also shows | 3 |
positively correlated | 3 |
transcription pcr | 3 |
koch institute | 3 |
transmission among | 3 |
virus antibodies | 3 |
new insights | 3 |
kong authorities | 3 |
crude mortality | 3 |
pcr methods | 3 |
regression models | 3 |
prediction based | 3 |
children years | 3 |
literature shows | 3 |
transmission event | 3 |
tan hospital | 3 |
relatively low | 3 |
infective traveller | 3 |
viral clearance | 3 |
hev prevalence | 3 |
infectious agents | 3 |
bovine serum | 3 |
health beliefs | 3 |
among others | 3 |
nlr may | 3 |
another virus | 3 |
independently associated | 3 |
applied biosystems | 3 |
outbreak using | 3 |
nurses attending | 3 |
standardised cfr | 3 |
foetal bovine | 3 |
past pandemics | 3 |
chest computed | 3 |
bilateral lungs | 3 |
multiplex polymerase | 3 |
british hedgehogs | 3 |
disease threats | 3 |
field studies | 3 |
emerging infection | 3 |
different clinical | 3 |
public awareness | 3 |
acute cases | 3 |
potential domestic | 3 |
influenza surveillance | 3 |
case management | 3 |
china clinical | 3 |
baseline characteristics | 3 |
ecologic association | 3 |
preschool children | 3 |
protective measures | 3 |
laboratory diagnosis | 3 |
experimental settings | 3 |
nasopharyngeal samples | 3 |
field surveys | 3 |
four flows | 3 |
rub formulations | 3 |
fold higher | 3 |
shelter hospital | 3 |
using real | 3 |
specific population | 3 |
tier sources | 3 |
older siblings | 3 |
respiratory symptom | 3 |
healthcare determinants | 3 |
enrolled individuals | 3 |
common viruses | 3 |
potential pandemic | 3 |
key role | 3 |
variables including | 3 |
papers described | 3 |
shedding time | 3 |
university medical | 3 |
cases living | 3 |
among locations | 3 |
human sera | 3 |
united arab | 3 |
possible future | 3 |
testing facilities | 3 |
individuals within | 3 |
may present | 3 |
lung image | 3 |
bin abdulaziz | 3 |
limited settings | 3 |
predictive capacity | 3 |
overall incidence | 3 |
reproduction rate | 3 |
current illness | 3 |
normal distribution | 3 |
emerging covid | 3 |
study provides | 3 |
partial pressure | 3 |
ncdc case | 3 |
detection increased | 3 |
significant predictive | 3 |
one individual | 3 |
tests performed | 3 |
sample attended | 2 |
model considers | 2 |
average age | 2 |
control policies | 2 |
identify patients | 2 |
acute myocardial | 2 |
surface disinfectants | 2 |
many studies | 2 |
control detected | 2 |
vast majority | 2 |
existing respiratory | 2 |
infection rates | 2 |
diagnostic criteria | 2 |
cases day | 2 |
economic factors | 2 |
entire population | 2 |
dynamics approach | 2 |
serious health | 2 |
current evidence | 2 |
blueprint priority | 2 |
time step | 2 |
three clinical | 2 |
also varies | 2 |
chest distress | 2 |
tests conducted | 2 |
single population | 2 |
collection tubes | 2 |
declares global | 2 |
may improve | 2 |
poor correlation | 2 |
ethnic groups | 2 |
turnaround time | 2 |
social effects | 2 |
appropriate supportive | 2 |
viral agents | 2 |
longer duration | 2 |
midpoint estimation | 2 |
multivariate model | 2 |
requiring hospitalisation | 2 |
victorian infectious | 2 |
ksa moh | 2 |
medical attention | 2 |
pcr positive | 2 |
critical factors | 2 |
national institute | 2 |
health metrics | 2 |
least four | 2 |
frequently infected | 2 |
ct results | 2 |
targeted interventions | 2 |
second pair | 2 |
previously healthy | 2 |
without hypertension | 2 |
produced guidelines | 2 |
consequently greater | 2 |
antibody titres | 2 |
key parameter | 2 |
transferring boxes | 2 |
household crowding | 2 |
worst affected | 2 |
total daily | 2 |
children single | 2 |
transplant recipient | 2 |
states pharmacopeia | 2 |
governance indicators | 2 |
especially countries | 2 |
continuing professional | 2 |
younger children | 2 |
three times | 2 |
many reports | 2 |
extensive information | 2 |
protective factor | 2 |
identifying reservoirs | 2 |
referral center | 2 |
natural reservoirs | 2 |
cd cd | 2 |
source classification | 2 |
scoring countries | 2 |
seasonality components | 2 |
make contingency | 2 |
virus nucleic | 2 |
spread across | 2 |
study protocol | 2 |
human betacoronavirus | 2 |
shedding based | 2 |
analysis including | 2 |
virological testing | 2 |
health centre | 2 |
ari subjects | 2 |
remains infective | 2 |
richard title | 2 |
skiing holidays | 2 |
vaccination amongst | 2 |
perception item | 2 |
reproductive numbers | 2 |
cardiovascular complication | 2 |
diseases surveillance | 2 |
suspected symptoms | 2 |
china sars | 2 |
great challenges | 2 |
zoonotic diseases | 2 |
international emergency | 2 |
improved significantly | 2 |
rate due | 2 |
three non | 2 |
subsequent analysis | 2 |
centre study | 2 |
vereinigung zur | 2 |
important independent | 2 |
primers using | 2 |
virus excretion | 2 |
meier curve | 2 |
meier estimator | 2 |
protective materials | 2 |
burden placed | 2 |
business functions | 2 |
community settings | 2 |
infection cases | 2 |
faecal colour | 2 |
visit schedules | 2 |
collected covid | 2 |
cluster randomised | 2 |
general practice | 2 |
detection methods | 2 |
reported symptom | 2 |
first symptoms | 2 |
apparent disease | 2 |
repeated progression | 2 |
asymptomatic status | 2 |
epidemiologic study | 2 |
pneumonia lesions | 2 |
additional blood | 2 |
different settings | 2 |
sudanese camels | 2 |
distinct human | 2 |
entirely susceptible | 2 |
mixing assumption | 2 |
provide important | 2 |
early screening | 2 |
camel reservoir | 2 |
whether influenza | 2 |
survival curves | 2 |
exponential increase | 2 |
combined proportion | 2 |
sequencing using | 2 |
future scenarios | 2 |
household study | 2 |
sequences revealed | 2 |
will get | 2 |
susceptible people | 2 |
major waves | 2 |
virus mapping | 2 |
blocking disease | 2 |
active age | 2 |
emergency medical | 2 |
pcr cycle | 2 |
economic crisis | 2 |
increased nlr | 2 |
system drugs | 2 |
cellular control | 2 |
patients experiencing | 2 |
mycoplasma pneumoniae | 2 |
risk areas | 2 |
temporal relationship | 2 |
effectively control | 2 |
economic burden | 2 |
clinical utility | 2 |
influenza immunization | 2 |
quantitative suspension | 2 |
job loss | 2 |
en index | 2 |
road traffic | 2 |
flu symptoms | 2 |
data exclusions | 2 |
results indicate | 2 |
citric acid | 2 |
february march | 2 |
family study | 2 |
groups according | 2 |
sars transmission | 2 |
social media | 2 |
weekly household | 2 |
immune persons | 2 |
public databases | 2 |
tubes containing | 2 |
first sample | 2 |
two phases | 2 |
present two | 2 |
first described | 2 |
alcohol concentration | 2 |
specimens positive | 2 |
social structures | 2 |
immune dysfunction | 2 |
higher level | 2 |
public education | 2 |
first global | 2 |
health informatics | 2 |
contextualising public | 2 |
first reports | 2 |
demographic surveillance | 2 |
troponin i | 2 |
final version | 2 |
sheltered homeless | 2 |
single index | 2 |
major outbreaks | 2 |
risk period | 2 |
treatment centers | 2 |
longest rna | 2 |
testing strategy | 2 |
important indicators | 2 |
human mobility | 2 |
first batch | 2 |
using cross | 2 |
child index | 2 |
five family | 2 |
large public | 2 |
multiplicative time | 2 |
larger proportion | 2 |
larger sample | 2 |
six per | 2 |
risk settings | 2 |
community facility | 2 |
almost one | 2 |
precise detection | 2 |
ghsi scores | 2 |
significant results | 2 |
realistic estimate | 2 |
explore whether | 2 |
cov diagnosis | 2 |
mild alkaline | 2 |
hoc comparison | 2 |
infecting rsv | 2 |
wuhan keting | 2 |
higher among | 2 |
life technologies | 2 |
africa mapping | 2 |
drugs standard | 2 |
hand gels | 2 |
diagnostic test | 2 |
medical ethics | 2 |
swabs decreases | 2 |
persons outside | 2 |
federal capital | 2 |
yellow faeces | 2 |
shedding epidemiology | 2 |
soiled hands | 2 |
effective response | 2 |
definitive diagnostic | 2 |
reduced shedding | 2 |
surveillance network | 2 |
gene sequencing | 2 |
system capacity | 2 |
geographic differences | 2 |
hispanic population | 2 |
clinic research | 2 |
univariate ordinal | 2 |
model instead | 2 |
spread around | 2 |
symptomatic support | 2 |
first two | 2 |
public perception | 2 |
latino hispanics | 2 |
lower preparedness | 2 |
hospital settings | 2 |
regarding covid | 2 |
possible ways | 2 |
nationwide analysis | 2 |
antimicrobial efficacy | 2 |
wide range | 2 |
fever outbreak | 2 |
cases resulting | 2 |
made using | 2 |
prospectively collected | 2 |
contracting covid | 2 |
study set | 2 |
infection frequencies | 2 |
hospital mortality | 2 |
households included | 2 |
treatment guidelines | 2 |
virus genotype | 2 |
epidemic dynamics | 2 |
rhinoviruses reduce | 2 |
northeastern iran | 2 |
definite outcomes | 2 |
abnormal colour | 2 |
will also | 2 |
southern brazil | 2 |
case type | 2 |
standard control | 2 |
statistical associations | 2 |
pneumonia cases | 2 |
antibiotic treatment | 2 |
various factors | 2 |
cell infiltration | 2 |
nd february | 2 |
symptoms reported | 2 |
cases released | 2 |
negative patients | 2 |
disease mortality | 2 |
line listing | 2 |
incidence curve | 2 |
spreader events | 2 |
amino acid | 2 |
prognostic factor | 2 |
estimated case | 2 |
simultaneous detection | 2 |
infections compared | 2 |
study among | 2 |
increased testing | 2 |
based sanitisers | 2 |
inflammation biomarkers | 2 |
classic symptoms | 2 |
increasing demand | 2 |
pulmonary imaging | 2 |
age class | 2 |
seeking healthcare | 2 |
mers cov | 2 |
australian research | 2 |
axp ggbf | 2 |
health relevance | 2 |
close surveillance | 2 |
rate ratios | 2 |
cov incidence | 2 |
infections date | 2 |
antibodies increases | 2 |
countries based | 2 |
important role | 2 |
median rate | 2 |
identified patterns | 2 |
infectious influenza | 2 |
lower compared | 2 |
nucleotide differences | 2 |
luminex xtag | 2 |
data also | 2 |
individuals experiencing | 2 |
seegen inc | 2 |
carrier test | 2 |
sera bank | 2 |
virus interference | 2 |
nasal discharge | 2 |
highest quartile | 2 |
effective reproduction | 2 |
agarose gel | 2 |
european union | 2 |
field staff | 2 |
disease research | 2 |
physical flows | 2 |
economic disruptions | 2 |
accepted definition | 2 |
infections may | 2 |
flocked swabs | 2 |
important indicator | 2 |
knowledge may | 2 |
partially tested | 2 |
nearby country | 2 |
global data | 2 |
domestically bred | 2 |
specific symptoms | 2 |
making inferences | 2 |
data gaps | 2 |
something unexpected | 2 |
day post | 2 |
least two | 2 |
higher rates | 2 |
estimated value | 2 |
included within | 2 |
wide area | 2 |
country level | 2 |
future vaccine | 2 |
several key | 2 |
oi ezlsl | 2 |
intended practices | 2 |
contact patterns | 2 |
travel patterns | 2 |
recently reported | 2 |
old female | 2 |
spreading risk | 2 |
infected cattle | 2 |
interrupted time | 2 |
line represents | 2 |
variable called | 2 |
central drugs | 2 |
versus dual | 2 |
confirmed secondary | 2 |
autochthonous mers | 2 |
healthy participants | 2 |
pay attention | 2 |
erythrocyte sedimentation | 2 |
positive swab | 2 |
exported cases | 2 |
racing competitions | 2 |
ebola outbreak | 2 |
national level | 2 |
two consecutive | 2 |
preschool child | 2 |
coronavirus seroprevalence | 2 |
second model | 2 |
unexplained pneumonia | 2 |
practice guidelines | 2 |
using data | 2 |
may prevent | 2 |
estimating survival | 2 |
seasonal outbreak | 2 |
multivariate risk | 2 |
molecular testing | 2 |
subjective fever | 2 |
chronic lung | 2 |
likely applicable | 2 |
cluster randomized | 2 |
aldosterone system | 2 |
also made | 2 |
antimicrobial activity | 2 |
another important | 2 |
highly pathogenic | 2 |
prognostic factors | 2 |
transmission route | 2 |
total symptom | 2 |
unvaccinated cluster | 2 |
awareness campaign | 2 |
higher prevalence | 2 |
research network | 2 |
attenuated strain | 2 |
moderate illness | 2 |
multiple sources | 2 |
worldwide governance | 2 |
review shows | 2 |
peak concurrently | 2 |
healthcare delivery | 2 |
respiratory manifestations | 2 |
effective therapies | 2 |
concern regarding | 2 |
epidemic area | 2 |
like coronaviruses | 2 |
mechanical friction | 2 |
intensive therapy | 2 |
viral loads | 2 |
important limitations | 2 |
lowest tertile | 2 |
gross domestic | 2 |
spread globally | 2 |
five lung | 2 |
hubei outbreak | 2 |
unrelated pathogens | 2 |
infected person | 2 |
disease may | 2 |
cells significantly | 2 |
study indicated | 2 |
cases infected | 2 |
uncertainties related | 2 |
notification rates | 2 |